Stay updated with breaking news from Codexis Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) saw a significant drop in short interest in July. As of July 31st, there was short interest totalling 2,750,000 shares, a drop of 6.5% from the July 15th total of 2,940,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the short-interest ratio is presently 2.6 […]
Codexis (NASDAQ:CDXS – Free Report) had its target price trimmed by Stifel Nicolaus from $9.00 to $5.00 in a report issued on Monday, MarketBeat Ratings reports. The brokerage currently has a buy rating on the biotechnology company’s stock. Several other equities research analysts have also issued reports on the stock. HC Wainwright lowered shares of […]
White Pine Capital LLC increased its position in Codexis, Inc. (NASDAQ:CDXS – Free Report) by 13.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 249,106 shares of the biotechnology company’s stock after purchasing an additional 29,366 shares during the quarter. White Pine Capital LLC […]
White Pine Capital LLC raised its holdings in shares of Codexis, Inc. (NASDAQ:CDXS – Free Report) by 13.4% during the first quarter, according to its most recent filing with the SEC. The firm owned 249,106 shares of the biotechnology company’s stock after purchasing an additional 29,366 shares during the period. White Pine Capital LLC’s holdings […]
Codexis (NASDAQ:CDXS – Get Free Report) was downgraded by stock analysts at TD Cowen from an “outperform” rating to a “market perform” rating in a report issued on Monday, Marketbeat reports. They currently have a $4.00 price objective on the biotechnology company’s stock, down from their prior price objective of $21.00. TD Cowen’s price objective […]